Clinical Trial Update: Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic mesenchymal stem cell transplantation for tibial fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Fracture

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Tibial Fracture | Phase 2 | Status: COMPLETED